[Irritable bowel syndrome--role of motility inhibitors]

Internist (Berl). 2001 Apr;42(4):524-32. doi: 10.1007/s001080050787.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antidiarrheals / therapeutic use
  • Cholinergic Antagonists / therapeutic use
  • Colonic Diseases, Functional / drug therapy*
  • Colonic Diseases, Functional / physiopathology
  • Dietary Fiber / therapeutic use
  • Dopamine Antagonists / therapeutic use
  • Humans
  • Muscle Relaxants, Central / therapeutic use
  • Parasympatholytics / therapeutic use
  • Practice Guidelines as Topic
  • Randomized Controlled Trials as Topic
  • Serotonin Antagonists / therapeutic use
  • Surface-Active Agents / therapeutic use

Substances

  • Antidiarrheals
  • Cholinergic Antagonists
  • Dietary Fiber
  • Dopamine Antagonists
  • Muscle Relaxants, Central
  • Parasympatholytics
  • Serotonin Antagonists
  • Surface-Active Agents